Microsulis's microwave ablator approved in Canada
This article was originally published in Clinica
Executive Summary
Health Canada has approved the Acculis Accu2i percutaneous microwave tissue ablation (pMTA) system, developed by Microsulis Medical, for the coagulation of soft tissue during surgical procedures. The Acculis Accu2i delivers 2.45GHz of power to coagulate unwanted tissue masses, and consists of a 1.8mm diameter closed water-cooled needle. The Denmead, UK company CE marked the system in February 2010 for the treatment of liver and lung tumours, and it gained US clearance in August for the same indication (www.clinica.co.uk, 19 August 2010).